Urinary excretion of arbutin metabolites after oral administration of bearberry leaf extracts

Planta Medica

Volumn 71, Issue 2, 2005, Pages 147-152

  Quintus, Joachim ^a   Kovar, Karl Artur ^a   Link, Peter ^b   Hamacher, Harald ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LAZ Lab Arzneimittelprufung/Z   (Germany)

Author keywords

Arbutin; Arctostaphylos uva ursi; Bearberry leaf; Bioanalytics; Ericaceae; Pharmacokinetics

Indexed keywords

ARBUTIN; ARCTOSTAPHYLOS UVA URSI EXTRACT; DRUG METABOLITE; GLUCOSYLTRANSFERASE; GLUCURONIDE; HYDROQUINONE; HYDROQUINONE DERIVATIVE; HYDROQUINONE GLUCURONIDE; HYDROQUINONE SULFATE; METHYLARBUTIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ADULT; ANIMAL TISSUE; ARCTOSTAPHYLOS UVA URSI; ARTICLE; ASSAY; DRUG ELIMINATION; DRUG EXCRETION; DRUG STRUCTURE; FEMALE; FLUORESCENCE SPECTROSCOPY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLANT LEAF; RAT; SYNTHESIS; ULTRAVIOLET SPECTROSCOPY; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ARBUTIN; ARCTOSTAPHYLOS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; KIDNEY; MALE; MICROSOMES, LIVER; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; ARCTOSTAPHYLOS UVA-URSI; ERICACEAE; UVA URSI;

EID: 14944384932     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837782     Document Type: Article

References (16)

1. Hänsel R, Haas H. Therapie mit Phytopharmaka. Berlin: Springer Verlag, 1983: p 197
2. Dingermann T, Loew D. Phytopharmakologie. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2003: p 255
3. Alvarado F, Crane RK. Studies on the mechanism of intestinal absorption of sugars. VII. Phenylglycoside transport and its possible relationship to phlorizin inhibition of the active transport of sugars by the small intestine. Biochim Biophys Acta 1964; 93: 116-35
4. + and the active transport of arbutin in the small intestine. Biochim Biophys Acta 1965; 109: 478-94
5. Frohne D. Untersuchungen zur Frage der harndesinfizierenden Wirkungen von Bärentraubenblatt-Extrakten. Planta Med 1970; 18: 1-25
6. Paper DH, Koehler J, Franz G. Bioavailability of drug preparations containing a leaf extract of Arctostaphylos uva-ursi (L.) Sprengl. (Uvae ursi folium). Pharm Pharmacol Lett 1993; 3: 63-6
7. Siegers CP, Siegers JP, Pentz R, Bodinet C, Freudenstein J. Metabolism of arbutin from Uvae ursi extracts in humans. Pharm Pharmacol Lett 1997;7:90-2
8. Glöckl I, Blaschke G, Veit M. Validated methods for direct determination of hydroquinone glucuronide and sulphate in human urine a after oral intake of bearberry leaf extract by capillary zone electrophoresis. J Chromatogr B 2001; 761: 261-6
9. Werringloer J, Estabrook RW. Heterogeneity of liver microsomal cytochrome P450. The spectral characterization of reactants with reduced cytochrome P450. Arch Biochem Biophys 1975; 167: 270-86
10. Chemische Fabrik auf Aktien (vorm. E. Schering). Verfahren zur Herstellung von Hydrochinon und seinen Homologen. German Patent DE 81068 C, April 18th, 1895
11. Smits E, Engerts JBFN, Kellog RM, van Doren HA. Reliable method for the synthesis of aryl-β-D-glucopyranosides, using boron trifluoride-diethyl ether as catalyst. J Chem Soc, Perkin Trans 1996; 1: 2873-7
12. 12C-NMR without labelling. Phytochemistry 1995; 40: 801-6
13. Müller E (ed.). Methods of Organic Chemistry. Phenols part 1. Vol 6/1 (1); 4th edn Thieme, Stuttgart: 1976: p 447-81
14. Monograph "Uvae ursi folium". BAnz No. 109. June 15th, 1994
15. WHO. Hydroquinone (Environmental Health Criteria 150), International Programme on Chemical Safety. Geneva: 1994
16. Schindler G, Patzak U, Brinkhaus B, von Nieciecki A, Wittig J, Kraehmer N, Veit M. Urinary excretion and metabolism of arbutin after oral administration of Arctostaphyios uvae ursi extracts as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol 2002; 42: 920-7